Collaboration Between a Greek and an American Company
"An innovative test, the product of a collaboration between a Greek and an American company, accurately detects, in just a few mins, the...
top of page
DIAGNOSTICS
ON THE SPOT
Rapid, affordable, powerful, AI-based diagnostic tests
right on your smartphone
Rapid and affordable lab-quality testing at the point-of-care and at home
The NanoSpot.ai rapid test combines a unique agglutination-based assay with an artificial-intelligence powered mobile application to deliver rapid, semi- quantitative, and instrument-free diagnostic results on site, in a point-of-care (POC) setting, and in an at-home testing environment.
Ultra-Fast
Sample to answer in under 3 minutes
Accurate
Results you can count on
Affordable
Enables insight in any environment
Semi-Quantitative
Results calibrated to international standards
Instrument-Free
Transforming cell phones into diagnostic instruments
Diagnostics in the palm of your hand
No need for expensive equipment. The combination of a special test card, integrated test calibrators, a user-friendly app, and artificial intelligence-based analysis allows for objective, semi-quantitative rapid testing results on your phone.
Play Video
Get results in 3 minutes and 5 easy steps
Explore our innovative testing platform
The NanoSpot.ai rapid immunoassay testing platform can be used for serology testing or blood grouping. Results can be stored on the phone, shared via email or text, saved as a pdf, printed, or integrated into Electronic Medical Records systems.
Blood Typing Test
The NanoSpot.ai rapid ABO/RhD Blood Typing Test allows safe, easy, accurate, and fast determination of your blood type and Rh factor on-site and at home.
SARS-CoV-2 antibody test
The NanoSpot.ai rapid SARS-CoV-2 Total Antibody test is a semi-quantitative Covid-19 antibody test that provides fast, accurate and semi-quantitative antibody level results.
The NanoSpot.ai SARS-CoV-2 Total Antibody Test has been CE Marked.
The NanoSpot.ai SARS-CoV-2 Total Antibody Test has not been FDA cleared, approved, or authorized under an emergency use authorization.
The NanoSpot.ai Website may depict certain of our future planned care offerings which are subject to completion of development and may require regulatory authorization, clearance, or approval before they can be commercialized.
Discover NanoSpot.ai Insights, our new global medical database
The NanoSpot.ai Insights Global Medical Database is currently being developed. It is aimed at providing global healthcare insights for healthcare providers, epidemiologists, public health officials, researchers and anyone else who is interested in global health data.
bottom of page